ALB and tetanus: Taken together we have obtained several sdAbs against albumin or IgG that enable tailored half-life extension of biologics in horse and swine, and most likely also dogs and cats, and have validated the long half-life of the albumin binding sdAb using a promising tetanus antitoxin in horse.